Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.
The ability of immune cells—particularly CD8 + T cells—to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies. However, the factors and ...
A mouse study reveals how aging immune cells may impair memory outside the brain, showing that blocking CD8+ T cell activity or their secreted factor, granzyme K, helped restore cognitive performance ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class ...
Cancer is the second leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives them to ...
The Brighterside of News on MSN
Cancer cells disarm T cells by stealing the molecules they need to fight
Blocking a tumor antioxidant restored T cell activity and made some resistant cancers more responsive to immunotherapy in ...
Researchers found that ATRA reduced terminal exhaustion in CD8+ T cells and enhanced anti-PD-1 therapy, improving tumor control and survival in glioma models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results